Stage IIIC Prostate Cancer AJCC v8 (DBCOND0109672)

Identifiers

Synonyms
Not Available

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT04519879
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CANo drug interventionstreatment2recruiting
NCT03899987
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgerytreatment2suspended
NCT04037254
Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancertreatment2active_not_recruiting
NCT03784677
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumorstreatment1completed
NCT04457245
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate CancerNo drug interventionsdiagnostic3terminated
NCT05806515
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutationtreatment2recruiting
NCT03581500
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate CancerNo drug interventionsdiagnostic2active_not_recruiting
NCT04927559
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation TherapyNo drug interventionsNot AvailableNot Availableterminated
NCT03570827
Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical ProstatectomyNo drug interventionstreatment2active_not_recruiting
NCT04134260
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancertreatment3recruiting
NCT03279250
Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancertreatment2completed
NCT04447703
Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET StudyNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT04725903
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04947254
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancertreatment2recruiting
NCT04318028
An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate CancerNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT03575832
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their PartnersNo drug interventionspreventionNot Availableactive_not_recruiting
NCT04189770
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their PartnersNo drug interventionsNot AvailableNot Availablerecruiting
NCT04945642
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate AdenocarcinomaNo drug interventionstreatmentNot Availablerecruiting
NCT05320406
RElugolix VErsus LeUprolide Cardiac Trialtreatment4active_not_recruiting
NCT04288336
Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical ProstatectomyNo drug interventionsprevention0withdrawn
NCT04501913
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05627219
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND NetworkNo drug interventionsNot AvailableNot Availablerecruiting
NCT04513717
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trialtreatment3recruiting
NCT04981834
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05676463
MRI Guided Radiation Therapy for the Treatment of High Risk Prostate CancerNo drug interventionstreatment2suspended
NCT04976257
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusiontreatment0completed
NCT03218826
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgerytreatment1active_not_recruiting
NCT03707574
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03177460
Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancertreatment1completed
NCT04067960
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerNo drug interventionsscreening0completed
NCT04215029
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African AmericansNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04915508
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical ProstatectomyNo drug interventionstreatment2recruiting